Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Hye-Lin Kim, Kyung-Ah Kim, Gwang Hyun Choi, Eun Sun Jang, Moran Ki, Hwa Young Choi, Sook-Hyang Jeong

Clin Mol Hepatol. 2022;28(1):91-104. Published online November 5, 2021

DOI: https://doi.org/10.3350/cmh.2021.0236

View: 9727 Download: 184 Web of Science: 11 Crossref: 10

Hae-Sook Shon, Hwa Young Choi, Jang Rak Kim, So Yeon Ryu, Youn-Jae Lee, Myeong Jin Lee, Hyun Ju Min, Jun Lee, Yeong Jun Song, Moran Ki

Clin Mol Hepatol. 2015;21(3):249-256. Published online September 30, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.3.249

View: 8708 Download: 83 Web of Science: 13 Crossref: 12

Donghun Lee, Moran Ki, Anna Lee, Kyoung-Ryul Lee, Hee Bong Park, Chang Sub Kim, Bo Young Yoon, Jong Hyun Kim, Young Sok Lee, Sook-Hyang Jeong

Clin Mol Hepatol. 2011;17(1):44-50. Published online March 21, 2011

DOI: https://doi.org/10.3350/kjhep.2011.17.1.44

View: 6448 Download: 58 Crossref: 17

1 |

Viewed By 5396	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 5362	MAFLD: How is it different from NAFLD?
Viewed By 5245	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3924	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 3901	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 114	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 103	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 76	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 68	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 52	MAFLD: How is it different from NAFLD?

Search